Shamim Ruff, SVP, Regulatory Affairs & Qual at Sarepta Therapeutics, Inc. (SRPT), sold 10,000 shares at $55.00 ($550K) on 2017-11-06, disclosed to the SEC on 2017-11-08.
Open-market sale of $550k SRPT by SVP, Regulatory Affairs & Qual. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SRPT | SELL | 2017-10-05 | $575K | — | Filing → |
| SRPT | SELL | 2017-07-21 | $522K | — | Filing → |
| SRPT | SELL | 2016-09-30 | $439K | — | Filing → |